Clinical Trial Update: Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pacritinib with azacitidine or decitabine as a bridge to allogeneic stem cell transplantation in patients with accelerated and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Accelerated-phase Myeloproliferative Neoplasm
• Blast-phase Myeloproliferative Neoplasm

Drugs mentioned

• Dacogen (decitabine)
• Pacritinib (pacritinib)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: University of Washington | Conditions: Accelerated Phase Myeloproliferative Neoplasm, Blast Phase Myeloproliferative Neoplasm | Phase 2 | Status: RECRUITING